DFIN vs NBIX · P/E 20, rev $429.7M vs P/E 45, rev $1.77B
Donnelley Financial Solutions Inc (DFIN) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Donnelley Financial Solutions Inc (DFIN) is a software - application company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DFIN revenue for 2026-06-30 was $429.7M. Net income was $69.9M. DFIN currently screens at market cap $1.69B and trailing P/E 20.2.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
DFIN currently screens at market cap $1.69B and trailing P/E 20.2. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the DFIN and NBIX stock pages for the full models.
Not investment advice.